retatrutide study results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Thailand | Medically Supervised

Ara-290 is investigational and not approved by the FDA or any regulator it has been evaluated through Phase 2 trials only and is presented for research and educational use only

T.YinW.GarousiJ.GrslundT.et al (2024)

Maintenance Calories The number of calories required to maintain current body weight without gaining or losing

The Canadian research community has increasingly explored these combinations, particularly as weight loss medications become more accessible

GLP-1 receptor agonists like semaglutide and tirzepatide create unique nutritional demands, and magnesium, involved in over 300 enzymatic reactions, may help support the body during this metabolic transition